Wellbutrin SR and Pregnancy: An Overview
Wellbutrin SR® (
bupropion SR) is a pregnancy Category C medicine, meaning that it could potentially cause harm to your unborn child.
Wellbutrin SR and Pregnancy Category C
The U.
S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that show side effects to the fetus in animal studies, but for which no adequate human studies in pregnant women have been done. A pregnancy Category C medicine may still be given to a pregnant woman if her healthcare provider believes that its benefits outweigh the possible risks to her unborn child.
During previous animal studies in which
bupropion (the active ingredient of
Wellbutrin SR) was given to pregnant rabbits, there was an increased risk of birth defects and lower fetal weights. In humans, preliminary studies suggest that bupropion may not cause any problems during pregnancy.
It is important to note that
depression in the mother may also not be healthy for a baby. Therefore, Wellbutrin SR may be given to a pregnant woman if her healthcare provider believes that its benefits outweigh any possible risks to her unborn child.